Our Leadership

Our Team

Mahesh Kandula, Managing Director & CEO

Drug Design and Development, Innovation & IP

Mahesh brings over >14 years of scientific and entrepreneurial experience in the life science industry. Mr. Kandula has been named an inventor on 72 United States Issued Patents, 29 United States Patent Pending Applications and more than 181 International Patent Applications. Mr. Kandula received his Master of Technology degree from IIT Kharagpur.

Ashok Rampal., Senior Scientific Advisor

Formulation development

Ashok Rampal has more than 3 decades of experience in R & D management, drug delivery and formulation development in renowned companies like Knoll Pharmaceuticals, Ranbaxy-Lilly, Ranbaxy Research Labs and Alkem Labs Ltd. Mr. Rampal holds Master’s degree in Pharmaceutics from Panjab University and Diploma in Business Management from Mumbai. He is inventor in more than 110 patent applications.

K B Sunil Kumar., Senior Scientific Advisor

Pre-Clinical development

Specialized in pharmaceutical toxicology and preclinical development with more than 25 years of professional experience in Drug Discovery and Development. Record of accomplishment of leading the planning, execution and authoring multiple successful Investigational New drug applications [INDs] in different therapeutic areas with global regulatory authorities. Dr. Sunil Kumar holds a Ph.D from University of Kerala, Thiruvananthapuram, Kerala, India.

Dr. Nilanjan Saha., Senior Advisor

Medical and Clinical Affairs

Dr. Nilanjan Saha is a medical research professional with expertise in new product evaluations, positioning of drugs in Therapy and ethical marketing. He is an active proponent of Antibiotic Stewardship. In the past, he has extensively involved in Volunteer studies with generic and NCEs; Phase I to III Clinical trials with anti-cancer and anti-malarial NCEs. His main interest is Clinical Development strategies for new Pharmaceutical products.

Sivanesan P., Associate Director

Pre-Clinical development

Sivanesan has > 12 years of experience in nonclinical development of various pharmaceutical products. Experienced in planning and conducting nonclinical studies for new chemical entities and evaluating the safety profile of a drug candidate in various therapeutic areas. He received bachelor degree in Veterinary Science and Master Degree in Veterinary pathology. He is also a certified Diplomate of American Board of Toxicology [DABT].